STOCK MARKET BSE NSE

Panel formed to study Pentavalent vaccine issues

THIRUVANANTHAPURAM: A committee has been constituted by the State Government to look into the issues and problems connected with  the pentavalent vaccine, that is soon to be included in t

Published: 16th September 2011 02:35 AM  |   Last Updated: 16th May 2012 07:04 PM   |  A+A-

THIRUVANANTHAPURAM: A committee has been constituted by the State Government to look into the issues and problems connected with  the pentavalent vaccine, that is soon to be included in the National Immunisation Programme. This move is in the wake of several complaints and concerns raised regarding the pentavalent vaccine from  various quarters, including the media, said Health Minister Adoor Prakash.

 The members of the committee which will study the issues related to the vaccine, especially safety and efficacy, are former head of the department of paediatrics, Thiruvananthapuram Medical College, Dr Noel Narayanan, head of the department of medicine Dr Lalitha Kailas, head of the department of community medicine at the Amrita Institute of Medical Science Dr Laila and Director of Health Services Dr P K Jameela.

It may be recalled that the government decision to vaccinate lakhs of children in the state with the controversial pentavalent vaccine from November-end had kicked up a lot of heat and dust not just in matters concerned with safety, but also with the efficacy of the vaccine.

The pentavalent, by combining vaccines for the regular diphtheria, pertusis, tetanus (DPT), hepatitis B and also the vaccine against Haemophilus influenzae type b (Hib), has been hailed for the reduction in the total number of shots for the babies and indirectly the equipment used such as the vials for storage and syringes.

The Hib vaccine is supposed to provide immunity against the dreaded meningitis and pneumonia, that may turn out to be fatal to children under the age of five.  However, immunisation programme with the pentavalent vaccine in several countries like Bhutan and Sri Lanka was followed with several adverse events, which led to the withdrawal of the vaccine for quite a long period of time.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp